Gh. Ryu et al., SURFACE CHARACTERISTICS AND PROPERTIES OF LUMBROKINASE-IMMOBILIZED POLYURETHANE, Journal of biomedical materials research, 29(3), 1995, pp. 403-409
Potent and never fibrinolytic enzymes (lumbrokinase [LK]) were extract
ed from the earthworm, Lumbricus rubellus. These enzymes were very sta
ble and showed greater antithrombotic activity than other currently us
ed fibrinolytic proteins. An LK fraction showing the most potent fibri
nolytic activity was immobilized onto a polyurethane (PU) surface to i
nvestigate its enzymatic activity and antithrombotic activity. A metha
nol-extracted PU surface was coated with 3% (wt/vol) maleic anhydride
methylvinyl ether copolymer (MAMEC)/tetrahydrofuran (THF) solution, an
d the surface was incubated in an LK solution/phosphate-buffered salin
e (PBS, pH 7.4). The surface properties were characterized by attenuat
ed total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR
), electron spectroscopy for chemical analysis (ESCA), and dynamic con
tact angle. The stability of immobilized LK was determined by caseinol
ytic activity assay and the specificity of immobilized LK on fibrinoge
n/fibrin was observed by sodium dodecyl sulphate-polyacrylamide gel el
ectrophoresis (SDS-PAGE). The antithrombotic activity of immobilized L
K was evaluated using an ex vivo rabbit A-A shunt experiment. LK immob
ilization was confirmed by ATR-FTIR and ESCA. Immobilized LK demonstra
ted stable proteolytic activity during various incubation periods. Imm
obilized LK proteolyzed fibrinogen and fibrin almost specifically, whi
le it hardly hydrolyzed other plasma proteins including plasminogen an
d albumin. In the ex vivo A-A shunt experiment, the LK-immobilized sur
face significantly prolonged occlusion time over control surfaces. Thi
s is primarily due to the high thrombolytic activity of immobilized LK
. In this work, a highly efficient surface modification method on the
PU surface was developed, and this LK immobilization technique will be
very useful in improving the blood compatibility of blood-contacting
devices. (C) 1995 John Wiley & Sons, Inc.